Key terms
About VRPX
Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Its products include metered-dose spray, liposomal gel encapsulates, and intranasal spray. The company was founded by Anthony P. Mack and Jeffrey A. Gudin in 2016 and and is headquartered in Berwyn, PA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest VRPX news
Mar 15
9:05am ET
Scilex enters release, settlement agreement with Virpax Pharmaceuticals
Feb 29
7:50pm ET
Virpax Pharmaceuticals Inc trading halted, news pending
Feb 27
7:51am ET
Virpax announces settlement of litigation with Sorrento and Scilex
Feb 27
7:39am ET
Virpax Pharmaceuticals announces 1-for-10 reverse stock split
Feb 08
3:10pm ET
Analysts Offer Insights on Healthcare Companies: Virpax Pharmaceuticals (VRPX) and I-MAB (IMAB)
Feb 07
7:36am ET
Virpax announces preliminary results of Probudur study with U.S. Army
No recent news articles are available for VRPX
No recent press releases are available for VRPX
VRPX Financials
Key terms
Ad Feedback
VRPX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
VRPX Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range